New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease - Université de Franche-Comté Accéder directement au contenu
Article Dans Une Revue Future Medicinal Chemistry Année : 2017

New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease

Houssem Boulebd
  • Fonction : Auteur
Helene Martin
  • Fonction : Auteur
Alexandre Bonet
  • Fonction : Auteur
Mourad Chioua
  • Fonction : Auteur
José Marco Contelles
  • Fonction : Auteur
Ali Belfaitah

Résumé

Aim: Due to the multifactorial nature of Alzheimer’s disease, there is an urgent search for new more efficient, multitarget-directed drugs. Results: This paper describes the synthesis, antioxidant and in vitro biological evaluation of ten (benz)imidazopyridino tacrines (7–16), showing less toxicity than tacrine at high doses, and potent cholinesterase inhibitory capacity, in the low micromolar range. Among them, compound 10 is a nonhepatotoxic tacrine at 1000 mM, showing moderate, but totally selective electric eel acetylcholinesterase inhibition, whereas molecule 16 is twofold less toxic than tacrine at 1000 μM, showing moderate and almost equipotent inhibition for electric eel acetylcholinesterase and equine butyrylcholinesterase. Conclusion: (Benz)imidazopyridino tacrines (7–16) have been identified as a new and promising type of tacrines for the potential treatment of Alzheimer’s disease.
Fichier non déposé

Dates et versions

hal-03654691 , version 1 (28-04-2022)

Identifiants

Citer

Houssem Boulebd, Lhassane Ismaili, Helene Martin, Alexandre Bonet, Mourad Chioua, et al.. New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease. Future Medicinal Chemistry, 2017, 9 (8), pp.723-729. ⟨10.4155/fmc-2017-0019⟩. ⟨hal-03654691⟩

Collections

UNIV-FCOMTE
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More